glp 1 and ms The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review Episode 444: A GLP-1 Drug
Description
Research presented at the American Academy of Orthopaedic Surgeons meeting in March 2026 linked GLP-1 use to nearly double the risk of bone density issues over five years
Most of the side effects reported from these medications have included GI issues like vomiting and nausea
, GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models, Diabetes 70, no
Is Ozempic safe for pregnancy
